BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8806107)

  • 1. GRP receptors are present in non small cell lung cancer cells.
    Moody TW; Zia F; Venugopal R; Fagarasan M; Oie H; Hu V
    J Cell Biochem Suppl; 1996; 24():247-56. PubMed ID: 8806107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Solubilization and purification of bombesin/gastrin releasing peptide receptors from human cell lines.
    Staley J; Coy DH; Jensen RT; Moody TW
    J Mol Neurosci; 1993; 4(1):29-40. PubMed ID: 8391295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of neuromedin B-preferring bombesin receptors on rat glioblastoma C-6 cells increases cellular Ca2+ and phosphoinositides.
    Wang LH; Battey JF; Wada E; Lin JT; Mantey S; Coy DH; Jensen RT
    Biochem J; 1992 Sep; 286 ( Pt 2)(Pt 2):641-8. PubMed ID: 1326946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Psi 13,14] bombesin analogues inhibit growth of small cell lung cancerin vitro and in vivo.
    Mahmoud S; Staley J; Taylor J; Bogden A; Moreau JP; Coy D; Avis I; Cuttitta F; Mulshine JL; Moody TW
    Cancer Res; 1991 Apr; 51(7):1798-802. PubMed ID: 1848479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuromedin B binds with high affinity, elevates cytosolic calcium and stimulates the growth of small-cell lung cancer cell lines.
    Moody TW; Staley J; Zia F; Coy DH; Jensen RT
    J Pharmacol Exp Ther; 1992 Oct; 263(1):311-7. PubMed ID: 1328611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Des-Met14]bombesin analogues function as small cell lung cancer bombesin receptor antagonists.
    Staley J; Coy D; Taylor JE; Kim S; Moody TW
    Peptides; 1991; 12(1):145-9. PubMed ID: 1646997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The release of bombesin-like peptides from small cell lung cancer cells.
    Moody TW; Korman LY
    Ann N Y Acad Sci; 1988; 547():351-9. PubMed ID: 2853597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity receptors for bombesin/GRP-like peptides on human small cell lung cancer.
    Moody TW; Carney DN; Cuttitta F; Quattrocchi K; Minna JD
    Life Sci; 1985 Jul; 37(2):105-13. PubMed ID: 2409423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GRP-preferring bombesin receptors increase generation of inositol phosphates and tension in rat myometrium.
    Amiot F; Leiber D; Marc S; Harbon S
    Am J Physiol; 1993 Dec; 265(6 Pt 1):C1579-87. PubMed ID: 8279518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BW2258U89: a GRP receptor antagonist which inhibits small cell lung cancer growth.
    Moody TW; Venugopal R; Zia F; Patierno S; Leban JJ; McDermed J
    Life Sci; 1995; 56(7):521-9. PubMed ID: 7869832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction in receptors for bombesin and epidermal growth factor in xenografts of human small-cell lung cancer after treatment with bombesin antagonist RC-3095.
    Halmos G; Schally AV
    Proc Natl Acad Sci U S A; 1997 Feb; 94(3):956-60. PubMed ID: 9023364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of high-affinity receptors for bombesin/gastrin releasing peptide on the human prostate cancer cell lines PC-3 and DU-145: internalization of receptor bound 125I-(Tyr4) bombesin by tumor cells.
    Reile H; Armatis PE; Schally AV
    Prostate; 1994 Jul; 25(1):29-38. PubMed ID: 8022709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth inhibition of non-small-cell lung carcinoma by BN/GRP antagonist is linked with suppression of K-Ras, COX-2, and pAkt.
    Hohla F; Schally AV; Kanashiro CA; Buchholz S; Baker B; Kannadka C; Moder A; Aigner E; Datz C; Halmos G
    Proc Natl Acad Sci U S A; 2007 Nov; 104(47):18671-6. PubMed ID: 18003891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of bombesin/gastrin-releasing peptide receptors in human breast cancer and their relationship to steroid receptor expression.
    Halmos G; Wittliff JL; Schally AV
    Cancer Res; 1995 Jan; 55(2):280-7. PubMed ID: 7812958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell lung cancer bombesin receptors are antagonized by reduced peptide bond analogues.
    Mahmoud S; Palaszynski E; Fiskum G; Coy DH; Moody TW
    Life Sci; 1989; 44(5):367-73. PubMed ID: 2536883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM; Hoang DO; Feldman RI
    Mol Pharmacol; 1995 Apr; 47(4):871-81. PubMed ID: 7723750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bombesin activates MAP kinase in non-small cell lung cancer cells.
    Koh SW; Leyton J; Moody TW
    Peptides; 1999; 20(1):121-6. PubMed ID: 10098632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A potent bombesin receptor antagonist inhibits bombesin-stimulated growth of mouse colon cancer cells in vitro: absence of autocrine effects.
    Narayan S; Spindel ER; Rubin NH; Singh P
    Cell Growth Differ; 1992 Feb; 3(2):111-8. PubMed ID: 1323998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic stability and tumor inhibition of bombesin/GRP receptor antagonists.
    Davis TP; Crowell S; Taylor J; Clark DL; Coy D; Staley J; Moody TW
    Peptides; 1992; 13(2):401-7. PubMed ID: 1329046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of BIM26226, a potent and specific bombesin receptor antagonist, on amylase release and binding of bombesin-like peptides to AR4-2J cells.
    Dietrich JB; Hildebrand P; Jeker LB; Pansky A; Eberle AN; Beglinger C
    Regul Pept; 1994 Oct; 53(3):165-73. PubMed ID: 7531356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.